Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Could TPL be involved

<could it benefit them, in any way, having this action delayed? > IMO NO.

< strong NIRC response would put great pressure on them to deliver > IMO No. The opposite would be true. It would make it easier to deliver.

<They could finance their efforts by sale pf stock in PTSC if it were to appreciate significantly.> I don't think TPL has that many shares and I think it would take quite a few shares to finance their efforts at current prices.

Opty

Share
New Message
Please login to post a reply